A citation-based method for searching scientific literature

Soo Hyun Cho, Yeong Sim Choe, Seongbeom Park, Young Ju Kim, Hee Jin Kim, Hyemin Jang, Seung Joo Kim, Jun Pyo Kim, Young Hee Jung, Byeong C Kim, Duk L Na, Seung Hwan Moon, Sang Won Seo. Sci Rep 2020
Times Cited: 7







List of co-cited articles
38 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Billy Dunn, Samantha Budd Haeberlein, David M Holtzman, William Jagust, Frank Jessen, Jason Karlawish,[...]. Alzheimers Dement 2018
57

The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.
William E Klunk, Robert A Koeppe, Julie C Price, Tammie L Benzinger, Michael D Devous, William J Jagust, Keith A Johnson, Chester A Mathis, Davneet Minhas, Michael J Pontecorvo,[...]. Alzheimers Dement 2015
393
57

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study.
Osama Sabri, Marwan N Sabbagh, John Seibyl, Henryk Barthel, Hiroyasu Akatsu, Yasuomi Ouchi, Kohei Senda, Shigeo Murayama, Kenji Ishii, Masaki Takao,[...]. Alzheimers Dement 2015
290
42

[(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies.
Juha O Rinne, Dean F Wong, David A Wolk, Ville Leinonen, Steven E Arnold, Chris Buckley, Adrian Smith, Richard McLain, Paul F Sherwin, Gill Farrar,[...]. Acta Neuropathol 2012
63
42

Optimized classification of 18F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment.
Santiago Bullich, John Seibyl, Ana M Catafau, Aleksandar Jovalekic, Norman Koglin, Henryk Barthel, Osama Sabri, Susan De Santi. Neuroimage Clin 2017
66
42

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Guy M McKhann, David S Knopman, Howard Chertkow, Bradley T Hyman, Clifford R Jack, Claudia H Kawas, William E Klunk, Walter J Koroshetz, Jennifer J Manly, Richard Mayeux,[...]. Alzheimers Dement 2011
42

Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.
Lennart Thurfjell, Johan Lilja, Roger Lundqvist, Chris Buckley, Adrian Smith, Rik Vandenberghe, Paul Sherwin. J Nucl Med 2014
126
42

Mild cognitive impairment: clinical characterization and outcome.
R C Petersen, G E Smith, S C Waring, R J Ivnik, E G Tangalos, E Kokmen. Arch Neurol 1999
42

Optimal Reference Region to Measure Longitudinal Amyloid-β Change with 18F-Florbetaben PET.
Santiago Bullich, Victor L Villemagne, Ana M Catafau, Aleksandar Jovalekic, Norman Koglin, Christopher C Rowe, Susan De Santi. J Nucl Med 2017
34
42

Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity.
Sebastian Palmqvist, Michael Schöll, Olof Strandberg, Niklas Mattsson, Erik Stomrud, Henrik Zetterberg, Kaj Blennow, Susan Landau, William Jagust, Oskar Hansson. Nat Commun 2017
372
42

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.
William E Klunk, Henry Engler, Agneta Nordberg, Yanming Wang, Gunnar Blomqvist, Daniel P Holt, Mats Bergström, Irina Savitcheva, Guo-feng Huang, Sergio Estrada,[...]. Ann Neurol 2004
42

Alzheimer's disease: the amyloid cascade hypothesis.
J A Hardy, G A Higgins. Science 1992
42

The Cortical Neuroanatomy Related to Specific Neuropsychological Deficits in Alzheimer's Continuum.
Sung Hoon Kang, Yu Hyun Park, Daun Lee, Jun Pyo Kim, Juhee Chin, Yisuh Ahn, Seong Beom Park, Hee Jin Kim, Hyemin Jang, Young Hee Jung,[...]. Dement Neurocogn Disord 2019
64
28

A new Centiloid method for 18F-florbetaben and 18F-flutemetamol PET without conversion to PiB.
Soo Hyun Cho, Yeong Sim Choe, Hee Jin Kim, Hyemin Jang, Yeshin Kim, Si Eun Kim, Seung Joo Kim, Jun Pyo Kim, Young Hee Jung, Byeong C Kim,[...]. Eur J Nucl Med Mol Imaging 2020
16
28

Beta-amyloid imaging with florbetaben.
Osama Sabri, John Seibyl, Christopher Rowe, Henryk Barthel. Clin Transl Imaging 2015
96
28

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.
V Camus, P Payoux, L Barré, B Desgranges, T Voisin, C Tauber, R La Joie, M Tafani, C Hommet, G Chételat,[...]. Eur J Nucl Med Mol Imaging 2012
154
28

Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 Study.
John Seibyl, Ana M Catafau, Henryk Barthel, Kenji Ishii, Christopher C Rowe, James B Leverenz, Bernardino Ghetti, James W Ironside, Masaki Takao, Hiroyasu Akatsu,[...]. J Nucl Med 2016
61
28


Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.
Henryk Barthel, Hermann-Josef Gertz, Stefan Dresel, Oliver Peters, Peter Bartenstein, Katharina Buerger, Florian Hiemeyer, Sabine M Wittemer-Rump, John Seibyl, Cornelia Reininger,[...]. Lancet Neurol 2011
379
28

Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease.
Stephen Salloway, Jose E Gamez, Upinder Singh, Carl H Sadowsky, Teresa Villena, Marwan N Sabbagh, Thomas G Beach, Ranjan Duara, Adam S Fleisher, Kirk A Frey,[...]. Alzheimers Dement (Amst) 2017
49
28

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.
Rik Vandenberghe, Koen Van Laere, Adrian Ivanoiu, Eric Salmon, Christine Bastin, Eric Triau, Steen Hasselbalch, Ian Law, Allan Andersen, Alex Korner,[...]. Ann Neurol 2010
468
28

Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant.
Elizabeth C Mormino, Michael G Brandel, Cindee M Madison, Gil D Rabinovici, Shawn Marks, Suzanne L Baker, William J Jagust. Neuroimage 2012
115
28



Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography.
Niklas Mattsson, Sebastian Palmqvist, Erik Stomrud, Jacob Vogel, Oskar Hansson. JAMA Neurol 2019
82
28

Neuroanatomical spread of amyloid β and tau in Alzheimer's disease: implications for primary prevention.
Philip S Insel, Elizabeth C Mormino, Paul S Aisen, Wesley K Thompson, Michael C Donohue. Brain Commun 2020
38
28

Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.
Peter T Nelson, Irina Alafuzoff, Eileen H Bigio, Constantin Bouras, Heiko Braak, Nigel J Cairns, Rudolph J Castellani, Barbara J Crain, Peter Davies, Kelly Del Tredici,[...]. J Neuropathol Exp Neurol 2012
28

Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease.
Jacob W Vogel, Yasser Iturria-Medina, Olof T Strandberg, Ruben Smith, Elizabeth Levitis, Alan C Evans, Oskar Hansson. Nat Commun 2020
153
28

Validation of an electronic image reader training programme for interpretation of [18F]flutemetamol β-amyloid PET brain images.
Christopher J Buckley, Paul F Sherwin, Adrian P L Smith, Jan Wolber, Sharon M Weick, David J Brooks. Nucl Med Commun 2017
43
28

Staging and quantification of florbetaben PET images using machine learning: impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes.
Jun Pyo Kim, Jeonghun Kim, Yeshin Kim, Seung Hwan Moon, Yu Hyun Park, Sole Yoo, Hyemin Jang, Hee Jin Kim, Duk L Na, Sang Won Seo,[...]. Eur J Nucl Med Mol Imaging 2020
9
28

Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios.
Susan M Landau, Allison Fero, Suzanne L Baker, Robert Koeppe, Mark Mintun, Kewei Chen, Eric M Reiman, William J Jagust. J Nucl Med 2015
189
28

Temporal trajectories of in vivo tau and amyloid-β accumulation in Alzheimer's disease.
Min Seok Baek, Hanna Cho, Hye Sun Lee, Jae Yong Choi, Jae Hoon Lee, Young Hoon Ryu, Myung Sik Lee, Chul Hyoung Lyoo. Eur J Nucl Med Mol Imaging 2020
17
28

Impact of beta-amyloid-specific florbetaben PET imaging on confidence in early diagnosis of Alzheimer's disease.
C G Schipke, O Peters, I Heuser, T Grimmer, M N Sabbagh, O Sabri, C Hock, M Kunz, J Kuhlmann, C Reininger,[...]. Dement Geriatr Cogn Disord 2012
55
28

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Howard H Feldman, Giovanni B Frisoni, Harald Hampel, William J Jagust, Keith A Johnson, David S Knopman,[...]. Neurology 2016
756
28

Subthreshold amyloid and its biological and clinical meaning: Long way ahead.
Gérard N Bischof, Heidi I L Jacobs. Neurology 2019
33
28

Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults.
Michelle E Farrell, Xi Chen, Melissa M Rundle, Micaela Y Chan, Gagan S Wig, Denise C Park. Neurology 2018
60
28

Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.
Gil D Rabinovici, Constantine Gatsonis, Charles Apgar, Kiran Chaudhary, Ilana Gareen, Lucy Hanna, James Hendrix, Bruce E Hillner, Cynthia Olson, Orit H Lesman-Segev,[...]. JAMA 2019
210
28

Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association.
Keith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, Kevin J Donohoe, Norman L Foster, Peter Herscovitch, Jason H Karlawish, Christopher C Rowe, Maria C Carrillo, Dean M Hartley,[...]. Alzheimers Dement 2013
324
28

Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.
Hyemin Jang, Young Kyoung Jang, Hee Jin Kim, David John Werring, Jin San Lee, Yeong Sim Choe, Seongbeom Park, Juyeon Lee, Ko Woon Kim, Yeshin Kim,[...]. Eur J Nucl Med Mol Imaging 2019
20
14

Machine Learning-based Individual Assessment of Cortical Atrophy Pattern in Alzheimer's Disease Spectrum: Development of the Classifier and Longitudinal Evaluation.
Jin San Lee, Changsoo Kim, Jeong-Hyeon Shin, Hanna Cho, Dae-Seock Shin, Nakyoung Kim, Hee Jin Kim, Yeshin Kim, Samuel N Lockhart, Duk L Na,[...]. Sci Rep 2018
23
14

Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.
N Tzourio-Mazoyer, B Landeau, D Papathanassiou, F Crivello, O Etard, N Delcroix, B Mazoyer, M Joliot. Neuroimage 2002
14


Effects of cerebrovascular disease and amyloid beta burden on cognition in subjects with subcortical vascular cognitive impairment.
Jae-Hyun Park, Sang Won Seo, Changsoo Kim, Sook Hui Kim, Geon Ha Kim, Sung Tae Kim, Seun Jeon, Jong Min Lee, Seung Jun Oh, Jae Seung Kim,[...]. Neurobiol Aging 2014
54
14

Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease.
Steven Ng, Victor L Villemagne, Sam Berlangieri, Sze-Ting Lee, Martin Cherk, Sylvia J Gong, Uwe Ackermann, Tim Saunder, Henri Tochon-Danguy, Gareth Jones,[...]. J Nucl Med 2007
170
14

Diagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
Elizabeth Morris, Anastasia Chalkidou, Alexander Hammers, Janet Peacock, Jennifer Summers, Stephen Keevil. Eur J Nucl Med Mol Imaging 2016
120
14

Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
James M Mountz, Charles M Laymon, Ann D Cohen, Zheng Zhang, Julie C Price, Sanaa Boudhar, Eric McDade, Howard J Aizenstein, William E Klunk, Chester A Mathis. Neuroimage Clin 2015
38
14

Infrequent false positive [18F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques.
Milos D Ikonomovic, Enrico R Fantoni, Gill Farrar, Stephen Salloway. Alzheimers Res Ther 2018
17
14

Amyloid Beta and Tau as Alzheimer's Disease Blood Biomarkers: Promise From New Technologies.
Lih-Fen Lue, Andre Guerra, Douglas G Walker. Neurol Ther 2017
62
14

Biochemistry and cell biology of tau protein in neurofibrillary degeneration.
Eva-Maria Mandelkow, Eckhard Mandelkow. Cold Spring Harb Perspect Med 2012
472
14

Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe.
Alexander Hammers, Richard Allom, Matthias J Koepp, Samantha L Free, Ralph Myers, Louis Lemieux, Tejal N Mitchell, David J Brooks, John S Duncan. Hum Brain Mapp 2003
753
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.